Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) had its price target boosted by equities research analysts at Morgan Stanley from $38.00 to $40.00 in a report released on Wednesday, Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Morgan Stanley‘s price target indicates a potential upside of 8.18% from the company’s previous close.
Several other equities research analysts have also recently weighed in on KDP. Argus restated a “buy” rating and issued a $36.00 price target on shares of Keurig Dr Pepper in a research report on Tuesday, September 15th. TD Cowen lifted their target price on Keurig Dr Pepper from $31.00 to $33.00 in a research report on Wednesday, July 8th. BNP Paribas Exane upped their price objective on shares of Keurig Dr Pepper from $28.00 to $29.00 and gave the stock a “neutral” rating in a research note on Monday, August 10th. Evercore raised their price target on shares of Keurig Dr Pepper from $30.00 to $32.00 in a report on Thursday, October 8th. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating and set a $42.00 target price on shares of Keurig Dr Pepper in a research report on Tuesday, August 4th. Ten analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $36.41.
Read Our Latest Research Report on KDP
Keurig Dr Pepper Stock Performance
Shares of KDP stock traded up $2.23 during trading hours on Wednesday, reaching $36.98. 10,489,907 shares of the company traded hands, compared to its average volume of 12,216,474. The company has a market cap of $50.32 billion, a P/E ratio of 37.16, a P/E/G ratio of 1.75 and a beta of 0.35. Keurig Dr Pepper has a 12-month low of $24.88 and a 12-month high of $37.04. The firm has a 50-day moving average price of $32.58 and a 200 day moving average price of $30.07. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.48 and a quick ratio of 0.28.
Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) last released its quarterly earnings data on Tuesday, November 3rd. The company reported $0.66 earnings per share for the quarter, topping analysts’ consensus estimates of $0.62 by $0.04. The firm had revenue of $7.34 billion during the quarter, compared to analyst estimates of $7.33 billion. Keurig Dr Pepper had a return on equity of 10.80% and a net margin of 7.10%. The business’s quarterly revenue was up 70.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.54 earnings per share. As a group, sell-side analysts predict that Keurig Dr Pepper will post 2.30 earnings per share for the current fiscal year.
Insider Buying and Selling at Keurig Dr Pepper
In other Keurig Dr Pepper news, insider Mary Beth Denooyer sold 12,000 shares of the company’s stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $32.55, for a total value of $390,600.00. Following the sale, the insider directly owned 84,171 shares of the company’s stock, valued at approximately $2,739,766.05. This represents a 12.48% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Angela Stephens sold 9,500 shares of the stock in a transaction dated Thursday, September 3rd. The stock was sold at an average price of $32.70, for a total value of $310,650.00. Following the sale, the vice president directly owned 55,786 shares in the company, valued at $1,824,202.20. This represents a 14.55% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.34% of the stock is owned by corporate insiders.
Institutional Investors Weigh In On Keurig Dr Pepper
Institutional investors have recently added to or reduced their stakes in the stock. Vontobel Holding Ltd. grew its position in shares of Keurig Dr Pepper by 1.5% in the third quarter. Vontobel Holding Ltd. now owns 21,777 shares of the company’s stock valued at $661,000 after purchasing an additional 328 shares during the period. Parallel Advisors LLC increased its holdings in shares of Keurig Dr Pepper by 2.6% in the third quarter. Parallel Advisors LLC now owns 13,823 shares of the company’s stock valued at $419,000 after purchasing an additional 353 shares during the last quarter. WJ Financial Advisors LLC lifted its position in Keurig Dr Pepper by 1.6% during the first quarter. WJ Financial Advisors LLC now owns 27,383 shares of the company’s stock worth $721,000 after buying an additional 433 shares in the last quarter. CX Institutional lifted its position in Keurig Dr Pepper by 2.8% during the third quarter. CX Institutional now owns 17,017 shares of the company’s stock worth $516,000 after buying an additional 469 shares in the last quarter. Finally, Vise Technologies Inc. boosted its stake in Keurig Dr Pepper by 4.0% during the third quarter. Vise Technologies Inc. now owns 14,081 shares of the company’s stock worth $427,000 after buying an additional 542 shares during the last quarter. Institutional investors and hedge funds own 93.99% of the company’s stock.
Key Stories Impacting Keurig Dr Pepper
Here are the key news stories impacting Keurig Dr Pepper this week:
- Positive Sentiment: KDP reported third-quarter adjusted EPS of $0.66, above analyst expectations of about $0.62–$0.63, while revenue of $7.34 billion was roughly in line with estimates. Profit and sales grew year over year. Reuters report on KDP’s quarterly results
- Positive Sentiment: Management reaffirmed its 2026 outlook, forecasting net sales of $25.9 billion to $26.4 billion. Growth across legacy segments and increased energy-drink market share—now above 10% following acquisitions—support the case for continued momentum. Outlook and planned separation
- Positive Sentiment: Piper Sandler raised its price target to $41 from $38, adding analyst support for the shares. Piper Sandler price-target update
- Neutral Sentiment: Reported sales growth of about 70% includes the contribution from the JDE Peet’s acquisition, so the headline increase does not reflect solely organic growth. KDP is also planning to separate its businesses in early 2027. Long-term investor takeaways
- Negative Sentiment: U.S. coffee remains a headwind: shoppers are trading down, and the company flagged slower coffee profits in the fourth quarter. This could limit margin growth despite strength in beverages. Report on coffee profit pressures
About Keurig Dr Pepper
Keurig Dr Pepper Inc (NASDAQ: KDP) is a beverage company that operates across coffee and packaged beverages. Its portfolio includes soft drinks, flavored waters, juices, juice drinks, ready-to-drink teas and coffees, sports and energy beverages, and mixers, as well as single-serve coffee brewing systems and pods.
The company’s brands include Keurig, Green Mountain Coffee Roasters, The Original Donut Shop, Dr Pepper, Canada Dry, Snapple, 7UP, A&W, Mott’s, Bai, CORE Hydration and Venom, among others.
Further Reading
- Five stocks we like better than Keurig Dr Pepper
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
- Washington Made a $2 Billion Quantum Bet, But Can Either ETF Match It?
- Bloom Energy: The Off-Grid Answer to AI’s Power Drain
Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.
